Skip to main content
MedPathMedPath Home
Clinical Trials/RPCEC00000239
RPCEC00000239
Not yet recruiting
Phase 2

Weekly paclitaxel concurrent with radiation therapy/Cisplatin in patients with cervical cancer of clinical stages IIb- IVA: PACORTCC study - PACORTCC

Cancerology State Institute, Colima State Health Service (SSA-Colima), Mexico0 sites30 target enrollmentFebruary 17, 2017
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsCervical cancerUterine Cervical NeoplasmsUterine NeoplasmsGenital Neoplasms, FemaleUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleNeoplasms

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Cervical cancer
Sponsor
Cancerology State Institute, Colima State Health Service (SSA-Colima), Mexico
Enrollment
30
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 17, 2017
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Cancerology State Institute, Colima State Health Service (SSA-Colima), Mexico

Eligibility Criteria

Inclusion Criteria

  • •1\. Women older than 18 years
  • •2\. Clinical and histological diagnosis of CaCU EC IIB\-IVA.
  • •3\. Histology of epidermoid carcinoma, adenocarcinoma, adenosquamous.
  • •4\. ECOG 0\-2\.
  • •5\. Patients with no history of Hepatic insufficiency or creatinine clearance less than 30mil / min.
  • •6\. Patients without sensory or motor neuropathy from any cause

Exclusion Criteria

  • •1\. Histology of small cells.
  • •2\. ECOG 3 or greater.
  • •3\. Diagnosis of second primary cancer.
  • •4\. Patients with diagnosed pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Weekly nab-Paclitaxel+Carboplatin with Radiotherapy as First Line Therapy in Patients with Advanced Non-Small-Cell Lung Canceron-Small-Cell Lung Cancer
JPRN-UMIN000031017niversity of Fukui Faculty of Medical Sciences25
Completed
Not Applicable
A study to look at the effects of combining chemotherapy and radiation treatments in advanced breast cancerHealth Condition 1: C508- Malignant neoplasm of overlappingsites of breast
CTRI/2021/02/031320Cancer Institute200
Completed
Phase 1
Paclitaxel plus cisplatin and concurrent radiation for unresectable, locally recurrent or remnant gastric cancer in the left upper abdomen – phase I studyunresectable, locally recurrent or remnant gastric cancer
JPRN-C000000246Multi-modality therapy for gastric cancer study group6
Not yet recruiting
Not Applicable
Concurrent chemoradiotherapy with paclitaxel and carboplatin for stage III or IVA cervical cancer with renal dysfunctioocally advanced stage III or IVA cervical cancer with renal dysfunction
JPRN-UMIN000026034Yokohama City University32
Completed
Phase 2
A phase II study of additional chemotherapy (neoadjuvant) followed by standard chemoradiation for locally advanced cervical carcinomaHealth Condition 1: C539- Malignant neoplasm of cervix uteri, unspecifiedHealth Condition 2: null- Squamous cell carcinoma of cervix, FIGO Stage IB2 to IVA.
CTRI/2012/07/002758Dr BR Ambedkar Institute Rotary Cancer Hospital20